Transcriptomic Biomarker Analysis – Pancreatic Cancer

Pancreatic cancer is one of the most aggressive cancers, often diagnosed at an advanced stage. Gene expression analysis helps identify key biomarkers to improve diagnosis, molecular classification, and therapeutic guidance.

Genes Analyzed in Pancreatic Cancer

Our panel targets major genes involved in tumor progression, including:

• KRAS – Mutation present in over 90% of pancreatic adenocarcinomas

• CDKN2A – Key role in cell cycle regulation

• SMAD4 – Alteration associated with metastatic progression

• TP53 – Frequent mutation impacting DNA repair and apoptosis

Applications & Benefits

• Patient stratification for targeted therapeutic approaches

• Early detection of molecular alterations

• Monitoring treatment response and tumor progression

• Identification of potential therapeutic targets

Technologies Used

We employ cutting-edge methods for precise and robust analysis:

• RT-qPCR and RNA-seq (NGS) for fine quantification of gene expression

• Nanostring and transcriptomic arrays for multiparametric analyses

• Epigenetic approaches to identify novel targets

Contact us at contact@genxmap.com for an analysis tailored to your molecular oncology project!